Sars-Cov-2 Mrna (Tozinameran 5Y-11Y) Vaccine Dosage
Usual Pediatric Dose for:
Additional dosage information:
Usual Pediatric Dose for COVID-19
For investigational use only
5 THROUGH 11 YEARS:
Primary Series: 0.2 mL IM for 2 doses, administered 21 days apart
- Third primary series dose (if indicated): 0.2 mL IM at least 28 days after the second dose
Booster Dose: 0.2 mL IM at least 5 months after completing a primary vaccine series
Comments:
- The US FDA issued an Emergency Use Authorization (EUA) to allow the emergency use of this unapproved product for active immunization to prevent coronavirus disease 2019 (COVID-19). This product is not approved by the US FDA for this use.
- There are no data available regarding interchangeability of COVID-19 vaccine products; the same vaccine product should be used for both doses.
- A third primary series dose is authorized for patients who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
- For additional information: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
Use: Active immunization to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Known history of severe allergic reactions (e.g., anaphylaxis) to the active component or to any of the ingredients
Safety and efficacy have not been established in patients younger than 5 years; this drug is not recommended for use in younger patients.
Dialysis
Data not available
Other Comments
Administration advice:
- For IM administration only. Do not inject IV, intradermally, or subcutaneously.
Storage requirements:
- Minimize exposure to room light and avoid exposure to direct sunlight and ultraviolet light; do not refreeze liquid vials.
- Vial storage prior to use: The Fact Sheet for Health Care Providers should be consulted regarding storage and subsequent thawing of frozen vials.
- Vial storage during use: If not previously thawed at 2C to 8C (35F to 46F), allow vials to thaw at room temperature (up to 25C [77F]) for 30 minutes.
- May store at room temperature (8C to 25C [46F to 77F]) for 12 hours total before dilution.
- After dilution, store between 2C to 25C (35F to 77F); discard vial 12 hours after dilution.
Reconstitution/preparation techniques:
- Requires dilution with sterile 0.9% Sodium Chloride Injection, USP, before administration.
- The Fact Sheet for Health Care Providers should be consulted.
General:
- This EUA pertains only to Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial with an orange cap and a label with an orange border, which is authorized for use in patients 5 through 11 years; carton labels state that this formulation is indicated for patients 5 to less than 12 years of age.
- Each 0.2 mL dose contains 10 mcg of a nucleoside-modified messenger RNA encoding the viral spike (S) glycoprotein of SARS-CoV-2.
- After dilution, vials contain ten 0.2 mL doses of vaccine.
- Low dead-volume syringes and/or needles can be used to extract 10 doses from a single vial; if standard syringes/needles are used, the volume may not be sufficient to extract 10 doses from the vial.
- Each dose must contain 0.2 mL of vaccine.
- If the vaccine remaining in the vial cannot provide a full 0.2 mL dose, discard the vial; do not pool excess vaccine from multiple vials.
Patient advice:
- Read the Vaccine Information Fact Sheet for Recipients and Caregivers.
- To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS): https://vaers.hhs.gov
More about sars-cov-2 mrna (tozinameran 5y-11y) vaccine
See also:
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
ACAM2000
ACAM2000 vaccine may be used to prevent smallpox and mpox disease in people of any age at high risk ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Afluria
Afluria is a vaccine used to prevent infection caused by influenza virus. Learn about side effects ...
Afluria Preservative-Free Pediatric Quadrivalent
Afluria Preservative-Free Pediatric Quadrivalent is used for influenza prophylaxis
Afluria Preservative-Free Quadrivalent
Afluria Preservative-Free Quadrivalent is used for influenza prophylaxis
Afluria Quadrivalent
Afluria Quadrivalent is used for influenza prophylaxis
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.